Homocysteine, B vitamins, and the incidence of dementia and cognitive impairment: Results from the Sacramento Area Latino Study on Aging

Mary N. Haan, Joshua W. Miller, Allison E. Aiello, Rachel Whitmer, William J. Jagust, Dan M Mungas, Lindsay H. Allen, Ralph Green

Research output: Contribution to journalArticle

187 Citations (Scopus)

Abstract

Background: High concentrations of homocysteine have been linked to a greater risk of Alzheimer disease, dementia, and cognitive decline. Objective: We evaluated the association between homocysteine and 4.5-y combined incidences of dementia and cognitive impairment without dementia (CIND) in a cohort of 1779 Mexican Americans aged 60-101 y. Design: Homocysteine, red blood cell (RBC) folate, and plasma vitamin B-12 were measured at baseline. New cases of dementia or CIND were ascertained by neuropsychological and clinical examinations and expert adjudication. We used proportional hazards models to estimate the risk of homocysteine-associated dementia or CIND and the influence of RBC folate and plasma vitamin B-12 on that association. Results: High homocysteine concentrations were associated with a greater risk of dementia or CIND: hazard ratio (HR): 2.39; 95% CI: 1.11, 5.16. Plasma vitamin B-12 modified the association between homocysteine and the outcome. The rates of dementia or CIND associated with homocysteine for those in the lowest and highest tertiles of vitamin B-12, respectively, were significantly higher (HR: 1.61, P = 0.04) and lower (HR: 0.94, P = 0.015) than the risk for those in the middle tertile. Conclusions: Homocysteine is an independent risk factor for both dementia and CIND. Higher plasma vitamin B-12 may reduce the risk of homocysteine-associated dementia or CIND.

Original languageEnglish (US)
Pages (from-to)511-517
Number of pages7
JournalAmerican Journal of Clinical Nutrition
Volume85
Issue number2
StatePublished - Feb 1 2007

Fingerprint

Vitamin B Complex
vitamin B complex
dementia
homocysteine
Homocysteine
Hispanic Americans
Dementia
incidence
Incidence
Vitamin B 12
vitamin B12
Cognitive Dysfunction
Folic Acid
folic acid
Alzheimer Disease
Erythrocytes
erythrocytes
Mexican Americans
risk estimate
Proportional Hazards Models

Keywords

  • B vitamins
  • Cognitive impairment without dementia
  • Dementia
  • Homocysteine
  • Red blood cell folate

ASJC Scopus subject areas

  • Medicine (miscellaneous)
  • Food Science

Cite this

Homocysteine, B vitamins, and the incidence of dementia and cognitive impairment : Results from the Sacramento Area Latino Study on Aging. / Haan, Mary N.; Miller, Joshua W.; Aiello, Allison E.; Whitmer, Rachel; Jagust, William J.; Mungas, Dan M; Allen, Lindsay H.; Green, Ralph.

In: American Journal of Clinical Nutrition, Vol. 85, No. 2, 01.02.2007, p. 511-517.

Research output: Contribution to journalArticle

@article{2c32b568291240d49219cd3300cee5c0,
title = "Homocysteine, B vitamins, and the incidence of dementia and cognitive impairment: Results from the Sacramento Area Latino Study on Aging",
abstract = "Background: High concentrations of homocysteine have been linked to a greater risk of Alzheimer disease, dementia, and cognitive decline. Objective: We evaluated the association between homocysteine and 4.5-y combined incidences of dementia and cognitive impairment without dementia (CIND) in a cohort of 1779 Mexican Americans aged 60-101 y. Design: Homocysteine, red blood cell (RBC) folate, and plasma vitamin B-12 were measured at baseline. New cases of dementia or CIND were ascertained by neuropsychological and clinical examinations and expert adjudication. We used proportional hazards models to estimate the risk of homocysteine-associated dementia or CIND and the influence of RBC folate and plasma vitamin B-12 on that association. Results: High homocysteine concentrations were associated with a greater risk of dementia or CIND: hazard ratio (HR): 2.39; 95{\%} CI: 1.11, 5.16. Plasma vitamin B-12 modified the association between homocysteine and the outcome. The rates of dementia or CIND associated with homocysteine for those in the lowest and highest tertiles of vitamin B-12, respectively, were significantly higher (HR: 1.61, P = 0.04) and lower (HR: 0.94, P = 0.015) than the risk for those in the middle tertile. Conclusions: Homocysteine is an independent risk factor for both dementia and CIND. Higher plasma vitamin B-12 may reduce the risk of homocysteine-associated dementia or CIND.",
keywords = "B vitamins, Cognitive impairment without dementia, Dementia, Homocysteine, Red blood cell folate",
author = "Haan, {Mary N.} and Miller, {Joshua W.} and Aiello, {Allison E.} and Rachel Whitmer and Jagust, {William J.} and Mungas, {Dan M} and Allen, {Lindsay H.} and Ralph Green",
year = "2007",
month = "2",
day = "1",
language = "English (US)",
volume = "85",
pages = "511--517",
journal = "American Journal of Clinical Nutrition",
issn = "0002-9165",
publisher = "American Society for Nutrition",
number = "2",

}

TY - JOUR

T1 - Homocysteine, B vitamins, and the incidence of dementia and cognitive impairment

T2 - Results from the Sacramento Area Latino Study on Aging

AU - Haan, Mary N.

AU - Miller, Joshua W.

AU - Aiello, Allison E.

AU - Whitmer, Rachel

AU - Jagust, William J.

AU - Mungas, Dan M

AU - Allen, Lindsay H.

AU - Green, Ralph

PY - 2007/2/1

Y1 - 2007/2/1

N2 - Background: High concentrations of homocysteine have been linked to a greater risk of Alzheimer disease, dementia, and cognitive decline. Objective: We evaluated the association between homocysteine and 4.5-y combined incidences of dementia and cognitive impairment without dementia (CIND) in a cohort of 1779 Mexican Americans aged 60-101 y. Design: Homocysteine, red blood cell (RBC) folate, and plasma vitamin B-12 were measured at baseline. New cases of dementia or CIND were ascertained by neuropsychological and clinical examinations and expert adjudication. We used proportional hazards models to estimate the risk of homocysteine-associated dementia or CIND and the influence of RBC folate and plasma vitamin B-12 on that association. Results: High homocysteine concentrations were associated with a greater risk of dementia or CIND: hazard ratio (HR): 2.39; 95% CI: 1.11, 5.16. Plasma vitamin B-12 modified the association between homocysteine and the outcome. The rates of dementia or CIND associated with homocysteine for those in the lowest and highest tertiles of vitamin B-12, respectively, were significantly higher (HR: 1.61, P = 0.04) and lower (HR: 0.94, P = 0.015) than the risk for those in the middle tertile. Conclusions: Homocysteine is an independent risk factor for both dementia and CIND. Higher plasma vitamin B-12 may reduce the risk of homocysteine-associated dementia or CIND.

AB - Background: High concentrations of homocysteine have been linked to a greater risk of Alzheimer disease, dementia, and cognitive decline. Objective: We evaluated the association between homocysteine and 4.5-y combined incidences of dementia and cognitive impairment without dementia (CIND) in a cohort of 1779 Mexican Americans aged 60-101 y. Design: Homocysteine, red blood cell (RBC) folate, and plasma vitamin B-12 were measured at baseline. New cases of dementia or CIND were ascertained by neuropsychological and clinical examinations and expert adjudication. We used proportional hazards models to estimate the risk of homocysteine-associated dementia or CIND and the influence of RBC folate and plasma vitamin B-12 on that association. Results: High homocysteine concentrations were associated with a greater risk of dementia or CIND: hazard ratio (HR): 2.39; 95% CI: 1.11, 5.16. Plasma vitamin B-12 modified the association between homocysteine and the outcome. The rates of dementia or CIND associated with homocysteine for those in the lowest and highest tertiles of vitamin B-12, respectively, were significantly higher (HR: 1.61, P = 0.04) and lower (HR: 0.94, P = 0.015) than the risk for those in the middle tertile. Conclusions: Homocysteine is an independent risk factor for both dementia and CIND. Higher plasma vitamin B-12 may reduce the risk of homocysteine-associated dementia or CIND.

KW - B vitamins

KW - Cognitive impairment without dementia

KW - Dementia

KW - Homocysteine

KW - Red blood cell folate

UR - http://www.scopus.com/inward/record.url?scp=33846875849&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33846875849&partnerID=8YFLogxK

M3 - Article

C2 - 17284751

AN - SCOPUS:33846875849

VL - 85

SP - 511

EP - 517

JO - American Journal of Clinical Nutrition

JF - American Journal of Clinical Nutrition

SN - 0002-9165

IS - 2

ER -